PureTech News

Press releases
Press Releases - 2023-03-01
Other
PureTech to Present at the Barclays Global Healthcare Conference
Continue
Press Releases - 2023-02-14
Seaport
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression
Continue
Press Releases - 2023-02-01
Other
PureTech to Present at the SVB Securities Global Biopharma Conference
Continue
Press Releases - 2023-01-06
Other
Akili
PureTech Founded Entity Akili Announces Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
Continue
Press Releases - 2022-12-22
Other
Wholly Owned Pipeline - LYT-100
PureTech Provides End of Year Report on Key Progress
Continue
Press Releases - 2022-12-19
Seaport
PureTech's LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
Continue
Press Releases - 2022-12-13
Other
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
Continue
Press Releases - 2022-12-12
Gallop Oncology – LYT-200
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
Continue
Press Releases - 2022-12-07
Vor
PureTech Founded Entity Vor Bio Announces First AML Patient Successfully Transplanted with its Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
Continue
Press Releases - 2022-11-30
Seaport
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech's Glyph™ Platform
Continue
Displaying 51 - 60 of 173

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH